A revolutionary new approach to rodent pest control

Welcome

Dissemination

One of the biggest parts of the project which is largely invisible is the enormous amount of work put in by the consortium members in terms of getting the message out it is almost like being an evangelist preacher spreading the word. All members of the consortium have actively participated in this message and we are fortunate with the group that they have such dynamic connections in the EU as well as further afield and they have been so proactive in their approach.

I would like to on behalf of PiedPiper’s members thank the EU Research Executive Agency for their faith in picking our project (after an extensive period of evaluation and due diligence) to fund us under the FP7 Research for the advantage of SME's grant 286852. Capacities section.

July 2016

Kenyatta university confirm successful wild rat field trials – running PiedPiper toxin 80mg dose and using a PiedPiper Pest Control Device.

Prime Minister John Key of the New Zealand Government announced the Zero Invasive Predators project to remove all non-indigenous mammals from NZ by 2050 www.zip.org.nz

EU announce the banning of anticoagulants for amateur / domestic use by 2018 and a further review of their use in the professional market in 2018/9.


May 2016
24/05/2016

PiedPiperDA final meeting held in the morning and followed by and open day / demonstration for interested parties – held at the IBIS hotel Schipol Airport.

24/05/2016

So, the final meeting is over - I would like to personally thank everyone and all the organisations that have worked with us, supported us and encouraged us. We have achieved an immense amount in PiedPiper DA. This FP7's was not supposed to be pioneering research but that is in effect what we have ended up doing. The project has developed a PCD despite administrative issues and longer lead times than projected by the suppliers. It has been an enormous success in terms of developing a viable alternative pest control system. Yes, we need now to move through the regulatory phase and then to market. Both stages require funding to get there.

April 2016
28/04/2016

PiedPiper received its first UK patent this month after having filed the first application in March 2009. The transdermal patent application was filed at the end of PiedPiper and now in PPDA is filing under PCT to cover 4.3 billion of the world's population.


December 2015

Held at Aston – the first view of the PCD design that had been approved and signed off at the Castelldefels meeting. All consortium members were impressed at the result and it was agreed to move to produce a pre-market version.

The unveiling of the latest specification PCD design
October 2015

First scale model of the prototype unveiled. The analysis of the consortium was that we needed to do better – so we revisited the specification and field requirements.

Second PPDA Prototype.

View of Pest Control Device external View of Pest Control Device internal

The consortium rejected this design for several reasons that made us revisit the specification process and sign off.

PiedPiperDA Evolution of the PCD – to the final prototype Trap 2.

Final Prototype
March 2015

Initial discussion of prototype specification.


February 2015
11/02/2015

Meeting of PiedPiper at IRIS Casteldefells head office to review progress and discuss prototype production.


December 2014
12/12/2014

Kick-off meeting of PiedPiper DA at Aston Business School.

22/12/2014

International Patent application files under PCT rules.


October 2013
30/10/2013

PiedPiper received its first UK patent this months after having filed the first application in March 2009. We have 20 more claims in process and intend to file further IP in the near future.


November 2013
02/11/2013

So the final meeting is over - I would like to personally thank everyone and all of the organizations that have worked with us, supported us and encouraged us. We have achieves an immense amount in PiedPiper. FP7's are not supposed to be pioneering research but that is in effect what we have ended up doing. The project has been an enormous success in terms of developing a viable alternative pest control system. Yes we need now to move through the regulatory phase and then to market. Both of these stages require funding to get there.

01/11/2013

Final meeting of the consortium PiedPiper - the next meeting will be under the new grant PiedPiper DA and will see a couple of changes in the structure of the group. EU rules do not allow RTD's to participate - all organizations have to be SME's. Thankfully IRIS an RTD in PiedPiper - will become a SME member of the PiedPiper DA. Aston and Burgos will not be members of the PiedPiper DA consortium but we will welcome some Aston staff and we will continue to receive consumables from University of Burgos.


I would like to on behalf of PiedPipers members thank the EU Research Executive Agency for their faith in picking our project (after an extensive period of evaluation and due diligence) to fund us under the FP7 Research for the advantage of SME's grant 286852. Capacities section.

Get in touch

If you have any questions or would like further information the please get in touch.